<DOC>
	<DOC>NCT00000302</DOC>
	<brief_summary>The purpose of this study is to compare liquid and tablet buprenorphine formulations.</brief_summary>
	<brief_title>Study Comparing Liquid and Tablet Buprenorphine Formulations - 5</brief_title>
	<detailed_description>Participants were inducted on either liquid or tablet buprenorphine, in a double-blind, double-dummy manner. They each reached a steady state by the second week, and were scheduled to have blood draws in weeks 3, 4, 7, 8, 11, 12, 15, and 16.</detailed_description>
	<mesh_term>Heroin Dependence</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>M/F ages 2150. Opiate dependence according to DSMIV criteria. Currently enrolled in the outpatient protocol comparing liquid and tablet formulations of Buprenorphine. Agreeable to conditions of study and signed informed consent. Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nursing women. Dependence on ETOH or benzodiazepines or other sedativehypnotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2002</verification_date>
</DOC>